These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

578 related items for PubMed ID: 20934489

  • 1. Effects of opioid agonist and antagonist in dams exposed to morphine during the perinatal period.
    Sobor M, Timár J, Riba P, Friedmann T, Király KP, Gyarmati S, Al-Khrasani M, Fürst S.
    Brain Res Bull; 2011 Jan 15; 84(1):53-60. PubMed ID: 20934489
    [Abstract] [Full Text] [Related]

  • 2. [Behavioural studies during the gestational-lactation period in morphine treated rats].
    Sobor M, Timár J, Riba P, Király KP, Al-Khrasani M, Gyarmati Z, Fürst Z.
    Neuropsychopharmacol Hung; 2013 Dec 15; 15(4):239-51. PubMed ID: 24380965
    [Abstract] [Full Text] [Related]

  • 3. Morphine sex-dependently induced place conditioning in adult Wistar rats.
    Karami M, Zarrindast MR.
    Eur J Pharmacol; 2008 Mar 17; 582(1-3):78-87. PubMed ID: 18191832
    [Abstract] [Full Text] [Related]

  • 4. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
    Cavun S, Göktalay G, Millington WR.
    J Pharmacol Exp Ther; 2005 Nov 17; 315(2):949-58. PubMed ID: 16079299
    [Abstract] [Full Text] [Related]

  • 5. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Stinus L, Cador M, Zorrilla EP, Koob GF.
    Neuropsychopharmacology; 2005 Jan 17; 30(1):90-8. PubMed ID: 15138444
    [Abstract] [Full Text] [Related]

  • 6. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK, Bhateja P, Singh TG, Singh N.
    Behav Pharmacol; 2008 May 17; 19(3):265-9. PubMed ID: 18469544
    [Abstract] [Full Text] [Related]

  • 7. Opiate regulation of behavioral selection during lactation.
    Sukikara MH, Platero MD, Canteras NS, Felicio LF.
    Pharmacol Biochem Behav; 2007 May 17; 87(3):315-20. PubMed ID: 17624414
    [Abstract] [Full Text] [Related]

  • 8. Opioid withdrawal for 4 days prevents synaptic depression induced by low dose of morphine or naloxone in rat hippocampal CA1 area in vivo.
    Dong Z, Han H, Cao J, Xu L.
    Hippocampus; 2010 Feb 17; 20(2):335-43. PubMed ID: 19437411
    [Abstract] [Full Text] [Related]

  • 9. Does the effect of morphine challenge change on maternal behaviour of dams chronically treated with morphine during gestation and further on during lactation?
    Sobor M, Timár J, Riba P, Király KP, Gyarmati S, Al-Khrasani M, Fürst S.
    Pharmacol Biochem Behav; 2010 May 17; 95(3):367-74. PubMed ID: 20193708
    [Abstract] [Full Text] [Related]

  • 10. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ, Bernstein RN, Wang Z, Sadée W, Porreca F.
    J Pharmacol Exp Ther; 1996 Apr 17; 277(1):484-90. PubMed ID: 8613958
    [Abstract] [Full Text] [Related]

  • 11. Ventral pallidal injections of a mu antagonist block the development of behavioral sensitization to systemic morphine.
    Johnson PI, Napier TC.
    Synapse; 2000 Oct 17; 38(1):61-70. PubMed ID: 10941141
    [Abstract] [Full Text] [Related]

  • 12. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
    Tsai RY, Tai YH, Tzeng JI, Cherng CH, Yeh CC, Wong CS.
    Neuroscience; 2009 Dec 01; 164(2):435-43. PubMed ID: 19682558
    [Abstract] [Full Text] [Related]

  • 13. GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine.
    Cabral A, Ruggiero RN, Nobre MJ, Brandão ML, Castilho VM.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar 17; 33(2):334-44. PubMed ID: 19150477
    [Abstract] [Full Text] [Related]

  • 14. Effects of alpha-lipoic acid administration on plasma glucose levels, total malondialdehyde values and withdrawal signs in rats treated with morphine or morphine plus naloxone.
    Pinelli A, Cighetti G, Trivulzio S.
    Arzneimittelforschung; 2009 Mar 17; 59(2):72-8. PubMed ID: 19338137
    [Abstract] [Full Text] [Related]

  • 15. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence.
    Liu J, Schulteis G.
    Pharmacol Biochem Behav; 2004 Sep 17; 79(1):101-8. PubMed ID: 15388289
    [Abstract] [Full Text] [Related]

  • 16. Naltrexone-induced conditioned place aversion following a single dose of morphine in the rat.
    White DA, Hwang ML, Holtzman SG.
    Pharmacol Biochem Behav; 2005 Jul 17; 81(3):451-8. PubMed ID: 15907990
    [Abstract] [Full Text] [Related]

  • 17. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence.
    Jin C, Araki H, Nagata M, Shimosaka R, Shibata K, Suemaru K, Kawasaki H, Gomita Y.
    Behav Brain Res; 2005 Jun 03; 161(1):107-12. PubMed ID: 15904717
    [Abstract] [Full Text] [Related]

  • 18. Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure.
    Heishman SJ, Stitzer ML, Bigelow GE, Liebson IA.
    J Pharmacol Exp Ther; 1989 Jan 03; 248(1):127-34. PubMed ID: 2913267
    [Abstract] [Full Text] [Related]

  • 19. Morphine pretreatment increases opioid inhibitory effects on maternal behavior.
    Miranda-Paiva CM, Nasello AG, Yin AJ, Felicio LF.
    Brain Res Bull; 2001 Jul 01; 55(4):501-5. PubMed ID: 11543950
    [Abstract] [Full Text] [Related]

  • 20. Effects of inactivating the agranular or granular insular cortex on the acquisition of the morphine-induced conditioned place preference and naloxone-precipitated conditioned place aversion in rats.
    Li CL, Zhu N, Meng XL, Li YH, Sui N.
    J Psychopharmacol; 2013 Sep 01; 27(9):837-44. PubMed ID: 23784741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.